Loading…
Loading…
EQUITY / NASDAQ · XNCM
Health In Tech Inc. Class A Common Stock
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.84 USD · 7.2249%
Observed: Oct 2, 2026, 10:07 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 0.7834 USD · Volume 329,508
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 8,056,620 USD | 9,313,849 USD | -13.50% |
| Net income | -2,511,024 USD | 630,631 USD | -498.18% |
| Cash and cash equivalents | 6,514,813 USD | — | — |
| Total liabilities | 10,010,308 USD | — | — |
| Total equity | 19,624,372 USD | 16,423,603 USD | +19.49% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 6,514,813 USD | — | — | 7,669,754 USD | 7,669,754 USD | 8,023,613 USD | — | — |
| Gross profitIncome statement | 3,922,493 USD | 8,431,892 USD | — | — | 20,937,728 USD | 5,143,816 USD | 16,809,085 USD | 6,309,870 USD |
| Net incomeIncome statement | -2,511,024 USD | -4,099,305 USD | -1,588,281 USD | — | 1,278,842 USD | 452,176 USD | 1,581,399 USD | 630,631 USD |
| RevenueIncome statement | 8,056,620 USD | 16,828,266 USD | — | — | 33,327,511 USD | 8,490,093 USD | 25,818,926 USD | 9,313,849 USD |
| Total assetsBalance sheet | 29,634,680 USD | — | — | 23,089,961 USD | 23,089,961 USD | 22,755,844 USD | — | — |
| Total equityBalance sheet | 19,624,372 USD | — | 21,603,148 USD | 17,112,065 USD | 17,112,065 USD | 17,158,963 USD | — | 16,423,603 USD |
| Total liabilitiesBalance sheet | 10,010,308 USD | — | — | 5,977,896 USD | 5,977,896 USD | 5,596,881 USD | — | — |
| Financing cash flowCash flow statement | — | 6,035,749 USD | — | — | -187,386 USD | — | -150,024 USD | — |
| Investing cash flowCash flow statement | — | -959,123 USD | — | — | -3,125,921 USD | — | -2,358,213 USD | — |
| Operating cash flowCash flow statement | — | -6,231,567 USD | — | — | 3,133,813 USD | — | 2,682,602 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/25/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.